Dysregulation of the DDR occurs through various mechanisms, including enhancement of tumor mutational burden (TMB) by PARP inhibition, leading to generation of neoantigens, which can promote the cytotoxic effects of T cells (Dall’Olio et al., 2022). The gene discussed is PARP1; the disease is neoplasm.